Evaluation of the Efficacy and Safety of Nano-S1
Condition:   COVID-19 Pneumonia Intervention:   Drug: NANOS1 , argent colloïdal , Sponsor:   General Administration of Military Health, Tunisia Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 20, 2023 Category: Research Source Type: clinical trials